# The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke

> **NCT02580838** · PHASE3 · UNKNOWN · sponsor: **National Cheng-Kung University Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** OnabotulinumtoxinA

## Key facts

- **NCT ID:** NCT02580838
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2023-09
- **Final completion:** 2025-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02580838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02580838, "The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02580838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
